Professional
Added to YB: 2024-01-23
Pitch date: 2024-01-23
MEDP [bullish]
Medpace Holdings, Inc.
+101.57%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$16.9B
Pitch Price
$301.77
Price Target
N/A
Dividend
N/A
EV/EBITDA
25.24
P/E
35.52
EV/Sales
5.95
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Vulcan Value holding: Medpace ($MEDP)
$MEDP: Clinical CRO beats expectations despite biotech funding challenges. Strong new biz, revenue, earnings & FCF. '24 guide above estimates. No debt, growing FCF, aligned mgmt. Stock responds positively.
Read full article (1 min)